4,991 Shares in Danaher Corporation $DHR Purchased by Krilogy Financial LLC

Krilogy Financial LLC acquired a new position in Danaher Corporation (NYSE:DHRFree Report) during the third quarter, HoldingsChannel reports. The institutional investor acquired 4,991 shares of the conglomerate’s stock, valued at approximately $1,059,000.

Several other large investors have also recently made changes to their positions in the business. ABC Arbitrage SA bought a new position in Danaher during the 3rd quarter valued at approximately $474,000. Stratos Wealth Partners LTD. grew its stake in shares of Danaher by 28.9% in the third quarter. Stratos Wealth Partners LTD. now owns 7,541 shares of the conglomerate’s stock worth $1,495,000 after acquiring an additional 1,689 shares during the last quarter. Baader Bank Aktiengesellschaft increased its holdings in shares of Danaher by 31.2% during the third quarter. Baader Bank Aktiengesellschaft now owns 12,604 shares of the conglomerate’s stock valued at $2,477,000 after acquiring an additional 2,998 shares in the last quarter. Cove Private Wealth LLC raised its position in shares of Danaher by 3.1% in the 3rd quarter. Cove Private Wealth LLC now owns 4,492 shares of the conglomerate’s stock worth $891,000 after purchasing an additional 135 shares during the last quarter. Finally, S&CO Inc. boosted its stake in Danaher by 8.2% in the 3rd quarter. S&CO Inc. now owns 13,189 shares of the conglomerate’s stock worth $2,614,000 after purchasing an additional 1,000 shares in the last quarter. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Danaher Trading Down 2.3%

Shares of DHR stock opened at $214.92 on Friday. The company has a current ratio of 1.87, a quick ratio of 1.51 and a debt-to-equity ratio of 0.35. Danaher Corporation has a 12-month low of $171.00 and a 12-month high of $242.80. The stock has a market capitalization of $151.81 billion, a P/E ratio of 42.64, a P/E/G ratio of 2.97 and a beta of 0.91. The firm’s 50 day moving average is $228.91 and its 200 day moving average is $215.40.

Danaher (NYSE:DHRGet Free Report) last released its quarterly earnings results on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share for the quarter, beating the consensus estimate of $2.14 by $0.09. The firm had revenue of $6.84 billion for the quarter, compared to analysts’ expectations of $6.79 billion. Danaher had a return on equity of 10.81% and a net margin of 14.71%.The company’s revenue was up 4.6% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.14 EPS. Research analysts expect that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, January 30th. Shareholders of record on Friday, December 26th were issued a $0.32 dividend. The ex-dividend date of this dividend was Friday, December 26th. This represents a $1.28 dividend on an annualized basis and a yield of 0.6%. Danaher’s dividend payout ratio is currently 25.40%.

Analysts Set New Price Targets

Several research analysts have issued reports on DHR shares. TD Cowen reaffirmed a “buy” rating on shares of Danaher in a report on Wednesday, January 7th. Evercore reissued an “outperform” rating and set a $254.00 price target on shares of Danaher in a research report on Wednesday, January 28th. KeyCorp reaffirmed an “overweight” rating on shares of Danaher in a research report on Thursday, January 29th. Morgan Stanley began coverage on Danaher in a research note on Monday, December 1st. They set an “overweight” rating and a $270.00 target price on the stock. Finally, Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Danaher in a research note on Thursday, January 29th. Twenty investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, Danaher currently has an average rating of “Moderate Buy” and an average target price of $253.86.

View Our Latest Report on Danaher

Insider Activity

In other Danaher news, Director Teri List sold 3,298 shares of the business’s stock in a transaction dated Tuesday, November 18th. The stock was sold at an average price of $226.50, for a total transaction of $746,997.00. Following the completion of the sale, the director directly owned 20,762 shares in the company, valued at $4,702,593. The trade was a 13.71% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 11.10% of the stock is currently owned by corporate insiders.

Danaher Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Featured Articles

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.